Skip to content

Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Dental Phobia

A Randomized Wait-list Control Study of the Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Patients With Dental Phobia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01207960
Acronym
EMDR-DP
Enrollment
24
Registered
2010-09-23
Start date
2010-01-31
Completion date
2011-09-30
Last updated
2012-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Phobia

Keywords

dental phobia, psychotherapy, eye movement desensitization and reprocessing - EMDR, efficacy, wait-list control

Brief summary

The purpose of this study is to find out whether Eye Movement Desensitization and Reprocessing (EMDR) is effective in the treatment of patients with dental phobia.

Detailed description

Dental phobia represents a clinical condition that affects 5-15% of the community and is characterized by severe anxiety of dental treatment which leads to avoidance of treatment and, as a consequence, severe dental as well as psychosocial problems. Eye Movement Desensitization and Reprocessing (EMDR) has been developed for the treatment of patients with post traumatic stress disorder (PTSD). Its efficacy in PTSD patients has often been demonstrated in randomized controlled trials. Recently it has been demonstrated that dental phobia is often induced by traumatic events during dental treatment and goes along with symptoms of PTSD in numerous patients. A pilot study (de Jongh et al. 2002) gave hints on the efficacy of EMDR in four dental phobia patients with a history of traumatization during dental treatment. This randomized wait-list control study aims to evaluate the efficacy of EMDR in a larger sample of dental phobia patients.

Interventions

The intervention consists of three 90-minute sessions of individual psychotherapy. Sessions take place weekly according to a treatment manual.

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* dental phobia according to the World Health Organization´s International Classification of Diseases, ICD-10 (F40.2)

Exclusion criteria

* schizophrenic disorder * severe depression * severe dissociative disorder * organic brain disease * anorexia nervosa (body mass index, BMI \< 17) * suicidality * severe cardio-vascular disease * ophthalmic disease * pregnancy and lactation * psychopharmacological treatment * substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Dental anxiety4 weeksDental anxiety is assessed by the Dental Anxiety Scale (DAS) and the Dental Fear Survey (DFS).

Secondary

MeasureTime frameDescription
General psychopathology4 weeks, 3 months, 12 monthsGeneral psychopathology is assessed by the Brief Symptom Scale (BSI).
Anxiety and depression4 weeks, 3 months, 12 monthsAnxiety and depression are assessed by the Hospital Anxiety and Depression Scale (HADS).
Behavioral test4 weeksDentral anxiety is assessed during a dental visit before and after treatment/wait-list control condition by means of a standardized behavior obeservation and interview.
Dental treatment3 months, 12 monthsDoes the patient tolerate dental treatment within 3 and 12 months after Eye Movement Desensitization and Reprocessing (EMDR)?

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026